))
FDA approves drugs for dogs with heart disease
Manage episode 434037323 series 3382848
Inhalt bereitgestellt von UF Health. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von UF Health oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
The U.S. Food and Drug Administration, or FDA, was busy this spring approving medications for dogs with heart disease.
Pimobendan [pea-moh-BEN-din] and torsemide [TORE-suh-mide] were approved for dogs in congestive heart failure — that’s fluid buildup due to heart disease, when it’s caused by myxomatous [mix-OH-mah-tus] mitral valve disease, or a thickened heart valve.
Pimobendan was also approved for dogs in congestive heart failure due to dilated cardiomyopathy, which involves an abnormal heart muscle. Both conditions are diagnosed with imaging tests.
Torsemide has conditional approval in combination with other medications used to treat congestive heart failure. That means it can be safely while its effectiveness is studied.
76 Episoden
Teilen
